SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kobo Biotech - Quaterly Results

13 Feb 2023 Evaluate
The revenue for the December 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2022 is Rs. -11.91 millions as compared to Net Loss of Rs. -13.48 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 improved to -1.66% as compared to -3.05% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.15 0.17 -11.76 0.17 0.36 -52.78
PBIDT -1.66 -3.05 -45.57 -6.91 -12.50 -44.72 -104.84 -27.54 280.68
Interest 0.00 0.00 0.00 0.00 1.35 -100.00 1.35 108.41 -98.75
PBDT -1.66 -3.05 -45.57 -6.91 -13.85 -50.11 -106.19 -135.95 -21.89
Depreciation 10.25 10.43 -1.73 30.68 34.24 -10.40 46.06 56.37 -18.29
PBT -11.91 -13.48 -11.65 -37.59 -48.09 -21.83 -152.25 -192.32 -20.84
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -11.91 -13.48 -11.65 -37.59 -48.09 -21.83 -152.25 -192.32 -20.84
Equity 238.25 238.25 0.00 238.25 238.25 0.00 238.25 238.25 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Share Price

2.74 0.12 (4.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×